South African Herbal Extracts as Potential Chemopreventive Agents: Screening for Anticancer Splicing Activity

  • Zodwa DlaminiEmail author
  • Zukile Mbita
  • David Bates
Part of the Methods in Molecular Biology book series (MIMB, volume 1379)


RT-PCR is an invaluable tool for the detection and characterization of mRNA. Cancer cell lines are treated with crude plant extracts and RNA is extracted and purified with DNase prior to RT-PCR. RT-PCR first-strand cDNA synthesis is done using random primers and can be refrigerated at 4 °C. PCR from the stored cDNA is performed using transcript-specific primers and electrophoresed on a molecular grade agarose gel to separate the splice variants.

Key words

Anticancer splicing activity Herbal plant extracts RNA extraction First-strand cDNA synthesis DNase treatment Agarose gel electrophoresis 



The British Royal Society, the South African Medical Research Council, the Oppenheimer Trust, and the National Research Foundation of South Africa supported this work.


  1. 1.
    Puckee T, Mkhize M, Zama M et al (2002) African traditional healers: what health care professionals need to know. Int J Rehabil Res 25:247–251CrossRefGoogle Scholar
  2. 2.
    Pajares MJ (2007) Alternative splicing: an emerging topic in molecular and clinical oncology. Lancet Oncol 8:349–357CrossRefPubMedGoogle Scholar
  3. 3.
    Venables JP (2004) Aberrant and alternative splicing in cancer. Cancer Res 64:7647–7654CrossRefPubMedGoogle Scholar
  4. 4.
    Faustino NA, Cooper TA (2003) Pre-mRNA splicing and human disease. Genes Dev 17:419–437CrossRefPubMedGoogle Scholar
  5. 5.
    Garcia-Blanco MA, Baranik AP, Lasda EL (2004) Alternative splicing in disease and therapy. Nat Biotechnol 22:535–546CrossRefPubMedGoogle Scholar
  6. 6.
    Pagani F, Baralle FE (2004) Genomic variants in exons and introns: identifying the splicing spoilers. Nat Rev Genet 5:389–396CrossRefPubMedGoogle Scholar
  7. 7.
    Hoimila R, Fouquet C, Cadranet J et al (2003) Splice mutations on the p53 gene case report and review of the literature. Hum Mutat 21:100–102Google Scholar
  8. 8.
    Hu CK, Madore SJ, Moldover B et al (2001) Predicying splice variant from DNA chip expression data. Genome Res 11:1237–1245PubMedCentralCrossRefPubMedGoogle Scholar
  9. 9.
    Black DL (2003) Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 72:291–336CrossRefPubMedGoogle Scholar
  10. 10.
    Colapietro P, Gervasini C, Natassi F et al (2003) Exon 7 skipping and sequence alterations in exonic splice enhancers (ESEs) in a neurofibromatosis patient. Hum Genet 113:551–554CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Research, Innovation & EngagementsMangosuthu University of TechnologyDurbanSouth Africa
  2. 2.Mangosuthu University of Technology Research, Innovation and Engagements PortfolioDurbanSouth Africa
  3. 3.Faculty of Medicine and Health Sciences, Division of Pre-clinical OncologyUniversity of NottinghamNottinghamUK

Personalised recommendations